2015
DOI: 10.1002/hep.28287
|View full text |Cite|
|
Sign up to set email alerts
|

Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease

Abstract: Surrogate indexes of insulin resistance and insulin sensitivity are widely used in nonalcoholic fatty liver disease (NAFLD), although they have never been validated in this population. We aimed to validate the available indexes in NAFLD subjects and to test their ability to predict liver damage also in comparison with the NAFLD fibrosis score. Surrogate indexes were validated by the tracer technique (6,6-D 2 -glucose and U-13 C-glucose) in the basal state and during an oral glucose tolerance test. The best-per… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
62
0
4

Year Published

2016
2016
2020
2020

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 66 publications
(71 citation statements)
references
References 53 publications
5
62
0
4
Order By: Relevance
“…We and others have shown that the cross‐talk between adipose tissue and liver is important in the development and progression of NAFLD, and that the presence of insulin resistance (IR) in liver, adipose tissue, and peripheral tissues is associated with hepatic dysfunction, that is, increased hepatic triglyceride re‐esterification, de novo lipogenesis and gluconeogenesis, and steatosis . Consistent with this, GLP‐1‐RAs have been shown to reduce body weight and hepatic steatosis in humans .…”
mentioning
confidence: 62%
See 1 more Smart Citation
“…We and others have shown that the cross‐talk between adipose tissue and liver is important in the development and progression of NAFLD, and that the presence of insulin resistance (IR) in liver, adipose tissue, and peripheral tissues is associated with hepatic dysfunction, that is, increased hepatic triglyceride re‐esterification, de novo lipogenesis and gluconeogenesis, and steatosis . Consistent with this, GLP‐1‐RAs have been shown to reduce body weight and hepatic steatosis in humans .…”
mentioning
confidence: 62%
“…The beneficial effects of GLP‐1 RA treatment on IR have important implications for treatment of patients with diabetes and NAFLD. In fact, previous studies have shown that Adipo‐IR is associated with a worse hepatic profile (histology and enzymes) in patients with NAFLD/NASH, and that the increased Adipo‐IR was associated with the improved liver histology . We also quantitated ATGU ( 18 FDG incorporation into abdominal subcutaneous fat during OGTT), which is required for adipocyte TG synthesis.…”
Section: Discussionmentioning
confidence: 99%
“…This finding suggests that the assessment of a narrowly available parameter such as insulin does not offer a significant advantage in the prediction of fibrosis risk when used in combination with classical components of MS. However, the lack of oral glucose insulin sensitivity (an expression of peripheral IR that predicts severe fibrosis more accurately than HOMA) could affect the interpretation of these results.…”
Section: Discussionmentioning
confidence: 99%
“…Nearly all nonalcoholic steatohepatitis (NASH) patients display insulin resistance independent of body weight (Chitturi et al 2002). In fact, peripheral insulin resistance is now considered a better predictor of hepatic injury in NAFLD than visceral adiposity or the commonly used fibrosis scoring system (Ercin et al 2015, Rosso et al 2016.…”
Section: Introductionmentioning
confidence: 99%